tiprankstipranks
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
US Market
GYRE
Gyre Therapeutics
RESEARCH TOOLSreports
Want to see GYRE full AI Analyst Report?

Gyre Therapeutics (GYRE) Stock News & Sentiment

827 Followers
Gyre Therapeutics Highlights Cullgen Acquisition and Pipeline Expansion
Premium
Company Announcements
Gyre Therapeutics Highlights Cullgen Acquisition and Pipeline Expansion
7d ago
8K
GYRE
Gyre Therapeutics’ F351 NDA Accepted for Priority Review
Premium
Company Announcements
Gyre Therapeutics’ F351 NDA Accepted for Priority Review
9d ago
8K
GYRE
GYRE Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
GYRE Upcoming Earnings Report: What to Expect?
16d ago
GYRE
Gyre Therapeutics Completes Cullgen Acquisition and Leadership Transition
Premium
Company Announcements
Gyre Therapeutics Completes Cullgen Acquisition and Leadership Transition
18d ago
8K
GYRE
Gyre Therapeutics Files NDA in China for F351
Premium
Company Announcements
Gyre Therapeutics Files NDA in China for F351
2M ago
8K
GYRE
Buy Rating on Gyre Therapeutics Driven by Priority Review of Hydronidone in China and De-Risked Path to 2026 Conditional Approval
Premium
Ratings
Buy Rating on Gyre Therapeutics Driven by Priority Review of Hydronidone in China and De-Risked Path to 2026 Conditional Approval
2M ago
GYRE
Gyre Therapeutics Faces Operational Risk From Rapid Shifts in Clinical Demand and Market Conditions
Premium
Company Announcements
Gyre Therapeutics Faces Operational Risk From Rapid Shifts in Clinical Demand and Market Conditions
2M ago
GYRE
More GYRE News >

GYRE News on the Web

Top Executive Makes Notable Move With Gyre Therapeutics Stock
TipRanks News
Neutral
Top Gyre Therapeutics Executive Makes Notable Move With Insider Stock Sale
TipRanks News
Neutral
Gyre Therapeutics Highlights Cullgen Acquisition and Pipeline Expansion
TipRanks News
Bullish
Gyre Therapeutics’ F351 NDA Accepted for Priority Review
TipRanks News
Bullish
Gyre Therapeutics announces China NMPA acceptance of F351 NDA
TipRanks News
Bullish
Noble Financial Sticks to Their Buy Rating for Gyre Therapeutics (GYRE)
TipRanks News
Bullish
Gyre Therapeutics reports Q1 EPS (10c) vs. 0c last year
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF), Sight Sciences (SGHT) and Gyre Therapeutics (GYRE)
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
GYRE
Sector Average
Media Buzz
This Week2 articles
Weekly Average2 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GYRE’s Media Buzz Sentiment?
2 articles about GYRE were published this week. In an average week, 2 articles are published.
    What is GYRE’s weekly average amount of articles?
    In an average week, 2 articles about GYRE are published.
      What is GYRE’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      GOSSGossamer Bio
      RLAYRelay Therapeutics
      IMVTImmunovant
      ROIVRoivant Sciences
      ILAIsland Pharmaceuticals Ltd
      Showing the stocks with the most bullish news sentiment over the past week